Orgenics moves into Germany:
This article was originally published in Clinica
Orgenics (Israel) has received approval for its diagnostic products in Germany. The company expects German sales to exceed $2 million over the next three years. Orgenics' products include rapid HIV tests which were recently approved by the World Health Organisation and the French licensing authorities (see Clinica No 650/651, p 23).
You may also be interested in...
The run-away US FDA advisory committee review of Biogen’s Alzheimer’s candidate was highly unusual. But like most things at the agency, not entirely unprecedented.
Trump Administration’s attempt to eliminate rebates in the US Medicare outpatient drug benefit program is the easiest and most certain item among the 11th hour pricing policy changes for the incoming Biden Administration to undo. But it still had a major impact on the dynamics of the drug pricing debate.
US FDA will simultaneously review the vaccines, with Moderna’s advisory committee set a week after Pfizer’s. ACIP emergency meeting scheduled for 1 December with vote likely on distribution priority for health care personnel.